References
- Tarlo SM, Cockroft DW, Dolovich J, Hargreave FE. Beclomethasone diproprionate aerosol in perennial rhinitis. J Allergy Clin Immunol 1977; 59: 232–6.
- Lindqvist N, Balle V, Karma P, et al. Long term safety and efficacy of budesonide nasal aerosol in perennial rhinitis -a 12 month multicenter study. Allergy 1986; 41: 179–86.
- Scadding GK, Lund VJ, Holmström M, Darby YC. Clinical and physiological effects of fluticasone propi-onate aqueous nasal spray in the treatment of perennial rhinitis. Rhinology 1991; 119 (Suppl.): 37–43.
- International Rhinitis Management Working Group. International consensus report on the diagnosis and management of rhinitis. Eur J Allergy Clin Immunol 1994; 49 (Suppl 19): 1–34.
- Mygind N, Nacleiro R. Intranasal corticosteroids. In: Nacleiro R, Durham S, Mygind N, eds. Rhinitis. Mech-anisms and management. New York: Marcel Dekker, 1999: 221–56.
- Davies RJ, Nelson H. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther 1997; 19: 1–12.
- Gip L, Lindberg L, Nordin P, Edwin AP. Clinical study of mometasone furoate cream 0,1% compared with hydrocortisone butyrate cream 0,1% in the treatment of atopic and seborrhoic dermatitis. Today's Ther Trends 1988; 5: 21–34.
- Rosenthal D, Duke E. A clinical investigation of the efficacy and safety of mometasone furoate ointment 0,1% vs. betamethasone valerate ointment 0,1% in the treatment of psoriasis. Curr Ther Res 1988; 44: 790–801.
- Vernon HJ, Lane AT, Weston W. Comparison of mometasone furoate 0,1% cream and hydrocortisone 1,0% cream in the treatment of childhood atopic der-matitis. J Am Acad Dermatol 1991; 24: 603–4.
- Meltzer E, Berger W, Berkowitz R, et al. A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1999; 104: 107–14.
- Brannan MD, Seiberling M, Cutler DL, Cuss FM, Affrime MB. Lack of systemic activity with intranasal mometasone furoate. J Allergy Clin Immunol 1996; 97: 198–204.
- Schenkel E, Skoner D, Bronsky E, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000; 105: 22–35
- Holopainen E, Malmberg H, Binder E. Long-term follow-up of intranasal beclomethasone treatment, a clinical and histological study. Acta Otolaryngol (Stockh) 1976; 182: 260–4.
- Minshall E, Ghaffar O, Cameron L, et al. Assessment by nasal biopsy of long-time use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998; 118: 648–54.
- Leone C, Teodoro C, Pelucchi A, et al. Bronchial responsiveness and airway inflammation in patients with non allergic rhinitis with eosinophilia syndrome. J Al-lergy Clin Immunol 1997; 100: 775–80.
- Estelle F, Simons R, Simons KJ. Optimum pharmaco-logical management of chronic rhinitis. Drugs 1989; 38: 313–31.
- Holmström M, Rosen G, Wahlander L. Effect of nasal lavage on nasal symptoms and physiology in wood industry workers. Rhinology 1997; 35: 108–12.